Antibiotic Therapy in the Treatment of COVID-19 Pneumonia: Who and When?

Background: COVID-19 imposes challenges in antibiotic decision-making due to similarities between bacterial pneumonia and moderate to severe COVID-19. We evaluated the effects of antibiotic therapy on the clinical outcomes of COVID-19 pneumonia patients and diagnostic accuracy of key inflammatory ma...

Descripción completa

Detalles Bibliográficos
Autores principales: Ng, Tat Ming, Ong, Sean W. X., Loo, Audrey Y. X., Tan, Sock Hoon, Tay, Hui Lin, Yap, Min Yi, Lye, David C., Lee, Tau Hong, Young, Barnaby E.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8868256/
https://www.ncbi.nlm.nih.gov/pubmed/35203787
http://dx.doi.org/10.3390/antibiotics11020184

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8868256/
https://www.ncbi.nlm.nih.gov/pubmed/35203787
http://dx.doi.org/10.3390/antibiotics11020184

Ejemplares similares